Bacterial surface epitopes (Multi-species)

This target entry represents a collective group of surface-exposed epitopes and antigens derived from a broad spectrum of Gram-positive and Gram-negative bacteria, including Staphylococcus, Streptococcus, Enterococcus, Proteus, Pseudomonas, Klebsiella, and Escherichia coli. These epitopes typically include cell wall components such as lipopolysaccharides, peptidoglycans, teichoic acids, and various surface proteins that are critical for bacterial structural integrity and host cell adhesion. In a therapeutic context, these epitopes serve as the primary targets for polyvalent bacterial vaccines and lysates designed to stimulate the host's mucosal and systemic immune systems. By presenting these antigens to the immune system, drugs targeting these epitopes aim to induce the production of protective antibodies and activate cellular immunity to prevent recurrent infections, particularly in the urinary and respiratory tracts. Because this 'target' is a heterogeneous collection of molecules across multiple genera rather than a single protein or receptor, it is primarily utilized in the development of immunomodulatory therapies and broad-spectrum prophylactic vaccines.

Other names

Bacterial surface antigensPolyvalent bacterial vaccine targetsBacterial cell wall componentsSurface-exposed epitopes

Induction of active immunity through the production of specific antibodies (IgA, IgG) and activation of T-lymphocytes against surface-exposed bacterial antigens, preventing bacterial adhesion and colonization.